This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
UnitedHealth Group, Inc. is the largest health care services company in the world, serving over 50 million individuals in the United States as of 2019 and over 5 million internationally. The company provides a wide range of health care products and services, such as health maintenance organizations (HMOs), point of service plans (POS), preferred provider organizations (PPOs), and managed fee-for-service programs. UnitedHealth has the largest and most diverse membership base within the managed-care organization market, which gives it significant competitive advantages. It also has built its prescription drug business through OptumRx division, with the acquisition of Catamaran in 2015.
Anthem's (ANTM) Q1 Earnings Miss Estimates, Improve Y/Y
by Zacks Equity Research
Anthem's (ANTM) Q1 results reflect solid growth across Government Business, offset by weak performance of Commercial & Specialty Business and Other segments.
Universal Health (UHS) Q1 Earnings, Revenues Miss Estimates
by Zacks Equity Research
Universal Health's (UHS) first-quarter earnings reflect pre-tax unrealized loss and higher expenses.
Stocks Continue to Rally as Coronavirus Cases Level Off
by David Borun
Fiscal and monetary stimuli help push US equities higher amid signs the curve is flattening.
SEM vs. UNH: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
SEM vs. UNH: Which Stock Is the Better Value Option?
The Zacks Analyst Blog Highlights: Comcast, Bristol-Myers Squibb, Walgreens Boots Alliance, UnitedHealth and Xcel Energy
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Comcast, Bristol-Myers Squibb, Walgreens Boots Alliance, UnitedHealth and Xcel Energy
Healthcare ETFs in Focus Post UnitedHealth's Q1 Earnings
by Sweta Killa
UnitedHealth reported mixed first-quarter 2020 results wherein it breezed past the Zacks Consensus Estimate on earnings but lagged the same for revenues.
Stock Market News for Apr 16, 2020
by Zacks Equity Research
Benchmarks closed in the red on Wednesday after investors accessed disappointing corporate earnings reports and weak economic data as a result of damage caused by the coronavirus outbreak.
Coronavirus Puts Digital Health in Focus: 3 Stocks to Watch
by Trina Mukherjee
Let's keep a watch on three stocks that are focusing on digital health to fight against coronavirus.
Top Research Reports for Comcast, Bristol-Myers & Walgreens
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Comcast (CMCSA), Bristol-Myers Squibb (BMY) and Walgreens Boots Alliance (WBA).
What's in Store for Dow ETFs in Q1 Earnings?
by Sweta Killa
With most blue-chip companies' earnings scheduled over the coming weeks, investors should closely monitor the movement of the Dow ETF.
Molina Healthcare Gains on Sanders' Exit From Presidential Race
by Zacks Equity Research
Molina Healthcare (MOH) gains from Bernie Sanders' withdrawal from the presidential campaign.
UnitedHeath (UNH) Beats on Q1 Earnings, Dodges Coronavirus Curse
by Zacks Equity Research
UnitedHealth's (UNH) Q1 earnings benefit from higher contribution at both its segments, escaping the fallout from the coronavirus-led crisis.
Retail Sales the Latest Record Low; Plus C, BAC, GS & More
by Mark Vickery
Retail Sales for the month of March was the latest economic read to plummet to all-time lows this morning: -8.7% was worse than the lowest in the range of estimates, and far below the upwardly revised -0.4% reported for February.
Economic Data Deluge
by Zacks Equity Research
Economic Data Deluge
UnitedHealth Group (UNH) Q1 Earnings Surpass Estimates
by Zacks Equity Research
UnitedHealth (UNH) delivered earnings and revenue surprises of 2.20% and -0.38%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Why UnitedHealth Group (UNH) Might Surprise This Earnings Season
by Zacks Equity Research
UnitedHealth Group (UNH) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
3 Highly-Ranked Stocks to Buy for the Coronavirus Economy & the Eventual Recovery
by Benjamin Rains
On today's episode of Full Court Finance, we explore three stocks that appear to be buys at the moment and down the road when the economy eventually turns around from the coronavirus downturn...
What's in the Cards for UnitedHealth's (UNH) Q1 Earnings?
by Zacks Equity Research
UnitedHealth's (UNH) Q1 earnings results to reflect gain from increase in revenues and the effect of share buyback.
The Zacks Analyst Blog Highlights: Facebook, JPMorgan Chase, UnitedHealth, BHP and Cognizant Technology Solutions
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Facebook, JPMorgan Chase, UnitedHealth, BHP and Cognizant Technology Solutions
The Zacks Analyst Blog Highlights: Molina Healthcare, Cigna, UnitedHealth, Anthem and Humana
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Molina Healthcare, Cigna, UnitedHealth, Anthem and Humana
Big Week of Q1 Earnings Coming Up
by Mark Vickery
Starting with the big banks and moving to companies working of a vaccine for COVID-19, we'll hope for the best and expect the worst.
7 Health Insurers Poised to Beat Earnings Estimates in Q1
by Zacks Equity Research
Health insurers are likely to gain from a solid revenue base, attributable to higher premiums across Medicare, Medicaid plans.
Q1 Earnings in Focus
by Zacks Equity Research
Q1 Earnings in Focus
UnitedHealth Group (UNH) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
UnitedHealth Group (UNH) closed the most recent trading day at $264.13, moving -1.38% from the previous trading session.
Stock Market News for Apr 9, 2020
by Zacks Equity Research
U.S. stocks ended sharply higher on Wednesday following investors' expectations that the U.S. economy may reopen earlier than it was previously decided.